BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23444773)

  • 1. Fanconi anemia pathway--the way of DNA interstrand cross-link repair.
    Yao CJ; Du W; Zhang Q; Zhang F; Zeng F; Chen FP
    Pharmazie; 2013 Jan; 68(1):5-11. PubMed ID: 23444773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA interstrand cross-link repair: understanding role of Fanconi anemia pathway and therapeutic implications.
    Shukla P; Solanki A; Ghosh K; Vundinti BR
    Eur J Haematol; 2013 Nov; 91(5):381-93. PubMed ID: 23859405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fanconi anemia: cellular and molecular features].
    Macé G; Briot D; Guervilly JH; Rosselli F
    Pathol Biol (Paris); 2007 Feb; 55(1):19-28. PubMed ID: 16904272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair.
    Mirchandani KD; D'Andrea AD
    Exp Cell Res; 2006 Aug; 312(14):2647-53. PubMed ID: 16859679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks.
    Macé-Aimé G; Couvé S; Khassenov B; Rosselli F; Saparbaev MK
    Environ Mol Mutagen; 2010 Jul; 51(6):508-19. PubMed ID: 20120016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C. elegans: a model of Fanconi anemia and ICL repair.
    Youds JL; Barber LJ; Boulton SJ
    Mutat Res; 2009 Jul; 668(1-2):103-16. PubMed ID: 19059419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay of Fanconi anemia proteins in the DNA damage response.
    Wang X; D'Andrea AD
    DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells.
    Kumaresan KR; Sridharan DM; McMahon LW; Lambert MW
    Biochemistry; 2007 Dec; 46(50):14359-68. PubMed ID: 18020456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in protein expression due to deleterious mutations in the FA/BRCA pathway.
    Salles D; Cabral RE; Pizzatti L; Bisch PM; Paixão JC; de Almeida CE; Seuánez HN; Cabral-Neto JB
    Biochem Biophys Res Commun; 2007 Dec; 364(4):755-60. PubMed ID: 17977515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fanconi anaemia/BRCA pathway.
    D'Andrea AD; Grompe M
    Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fanconi anemia pathway and DNA interstrand cross-link repair.
    Su X; Huang J
    Protein Cell; 2011 Sep; 2(9):704-11. PubMed ID: 21948210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.
    Escarceller M; Buchwald M; Singleton BK; Jeggo PA; Jackson SP; Moustacchi E; Papadopoulo D
    J Mol Biol; 1998 Jun; 279(2):375-85. PubMed ID: 9642044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic and molecular basis of Fanconi anemia.
    de Winter JP; Joenje H
    Mutat Res; 2009 Jul; 668(1-2):11-9. PubMed ID: 19061902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fanconi anemia is a highly penetrant cancer susceptibility syndrome.
    Dokal I
    Haematologica; 2008 Apr; 93(4):486-8. PubMed ID: 18379006
    [No Abstract]   [Full Text] [Related]  

  • 18. Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments.
    Kachnic LA; Li L; Fournier L; Willers H
    Cancer Lett; 2010 Jun; 292(1):73-9. PubMed ID: 20034732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fanconi anemia (cross)linked to DNA repair.
    Niedernhofer LJ; Lalai AS; Hoeijmakers JH
    Cell; 2005 Dec; 123(7):1191-8. PubMed ID: 16377561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional defects in the fanconi anemia pathway in pancreatic cancer cells.
    van der Heijden MS; Brody JR; Gallmeier E; Cunningham SC; Dezentje DA; Shen D; Hruban RH; Kern SE
    Am J Pathol; 2004 Aug; 165(2):651-7. PubMed ID: 15277238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.